Estrogen effects on MMP-13 and MMP-14 regulation of left ventricular mass in Dahl salt-induced hypertension

Gender Medicine

Volumn 5, Issue 1, 2008, Pages 74-85

  Dai, Qiuxia ^a   Lin, Jing ^a,b   Craig, Teresa ^b   Chou, Youn Min ^a   Hinojosa Laborde, Carmen ^b   Lindsey, Merry L ^a,b  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

aging; Dahl rats; estrogen; extracellular matrix; hypertension; left ventricular hypertrophy; matrix metalloproteinase

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGENASE 3; ESTRADIOL; FIBRONECTIN; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DAHL SALT SENSITIVE RAT; ENZYME REGULATION; ENZYME SYNTHESIS; ESTROGEN ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HYPERTENSION; HYPOTHESIS; IMMUNOBLOTTING; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; ESTROGENS; FEMALE; GENE EXPRESSION; HYPERTENSION; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 14; OVARIECTOMY; POSTMENOPAUSE; RATS; RATS, INBRED DAHL; TISSUE INHIBITOR OF METALLOPROTEINASES; VENTRICULAR REMODELING;

EID: 41949137816     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(08)80010-1     Document Type: Article

References (42)

1. Mendelsohn M. Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 3340 (1999) 1801-1811
2. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95 (1997) 252-264
3. Dubey R., Oparil S., and Imthurn B. Jackson EK. Sex hormones and hypertension. Cardiovasc Res 53 (2002) 688-708
4. Burt V., Whelton P., Rocella E., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-11991. Hypertension 225 (1995) 305-313
5. Staessen J., Bulpitt C., Fagard R., et al. The influence of menopause on blood pressure. J Hum Hypertens 3 (1989) 427-433
6. Hinojosa-Laborde C., and Lange D. Haywood JR. Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension 35 (2000) 4484-4489
7. Hinojosa-Laborde C., Craig T., Zheng W., et al. Ovariectomy augments hypertension in aging female Dahl salt-ssensitive rats. Hypertension 44 (2004) 4405-4409
8. Maric C. Sex differences in cardiovascular disease and hypertension: Involvement of the reninangiotensin system. Hypertension 46 (2005) 475-476
9. Maric C., and Sandberg K. Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol 15 (2004) 1546-1556
10. Ganau A., Devereux R., Roman M., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19 (1992) 1550-1558
11. Lindsey M. Spinale FG. Targeting matrix remodeling in cardiac hypertrophy and heart failure. Drug Discovery Today: Therapeutic Strategies 2 (2005) 253-258
12. Varagic J., Frohlich E., Diez J., et al. Myocardial fibrosis, impaired coronary hemodynamics. Am J Physiol Heart Circ Physiol 290 (2006) H1503-H1509
13. Weinberg E., Thienelt C., Katz S., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 334 (1999) 264-273
14. Pelzer T., Shamim A., Wolfges S., et al. Modulation of cardiac hypertrophy by estrogens. Adv Exp Med Biol 432 (1997) 83-89
15. Iwanaga Y., Aoyama T., Kihara Y., et al. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 39 (2002) 1384-1391
16. Lindsey M., Goshorn D., Squires C., et al. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Card diovasc Res 66 (2005) 4410-4419
17. Li H., Simon H., and Bocan T. Peterson JT. MMP/TIMP expression in spontaneously hypertensive heart failure rats: The effect of ACE-and MMP-inhibition. Cardiovasc Res 46 (2000) 298-306
18. Seccia T., Bettini E., Vulpis V., et al. Extracellular matrix gene expression in the left ventricular tissue of spontaneously hypertensive rats. Blood Press 88 (1999) 57-64
19. Robert V., Besse S., Sabri A., et al. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 76 (1997) 729-738
20. Lindsey M. MMP induction and inhibition in myocardial infarction. Heart Fail Rev 9 (2004) 7-19
21. Xu Y., Arenas I., and Armstrong S. Davidge ST. Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res 57 (2003) 388-394
22. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
23. Chou Y.-M., and Polansky A. Mason RL. Transforming non-normal data to normality in statistical process control. J Qual Technol 30 (1998) 133-141
24. Guo X., and Chapman D. Dhalla NS. Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan. Mol Cell Biochem 2254 (2003) 163-172
25. Zwadlo C., and Borlak J. Disease-associated changes in the expression of ion channels, ion receptors, ion exchangers and Ca(2+)-handling proteins in heart hypertrophy. Toxicol Appl Pharmacol 207 (2005) 244-256
26. Leichman J., Lavis V., Aguilar D., et al. The metabolic syndrome and the heart -a considered opinion. Clin Res Cardiol 95 Suppl 1 (2006) I134-I141
27. Sharma S., Adrogue J., Golfman L., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18 (2004) 1692-1700
28. Kleinbaum D., Kupper L., Muller K., and Nizam A. Applied Regression Analysis and Other Multivariable Methods (1997), Duxbury Press, Pacific Grove, Calif
29. Rothermel B., Berenji K., Tannous P., et al. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol Genomics 23 (2005) 18-27
30. Arias R. Cardiovascular health and the menopause: The gynecologist as the patients' interface. Climacteric 9 Suppl 1 (2006) 6-12
31. Simon T. Why is cardiovascular health important in menopausal women?. Climacteric 9 Suppl 1 (2006) 13-18
32. Jazbutyte V., Hu K., Kruchten P., et al. Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension 48 (2006) 579-586
33. Harrison-Bernard L., and Schulman I. Raij L. Post-ovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension 42 (2003) 1157-1163
34. Lobo R. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 75 Suppl 4 (1990) 18S-25S discussion 31S-35S
35. Shearer G., Joles J., Jones H., et al. Estrogen effects on triglyceride metabolism in analbuminemic rats. Kidney Int 57 (2000) 2268-2274
36. Dubey R., Oparil S., Imthrun B., and Jackson E. Sex hormones and hypertension. Cardiovasc Res 53 (2002) 688-708
37. Sasamura H., and Shimizu-Hirota R. Saruta T. Extracellular matrix remodeling in hypertension. Curr Hypertens Rev 1 (2005) 51-60
38. Keeley F., and Bartoszewicz L. Elastin in systemic and pulmonary hypertension. Ciba Found Symp 1192 (1995) 259-273 discussion 273-278
39. Xu C., Zarins C., Bassiouny H., et al. Differential transmural distribution of gene expression for collagen types I and III proximal to aortic coarctation in the rabbit. J Vasc Res 37 (2000) 170-182
40. Sluijter J., Smeets M., Velema E., et al. Increase in collagen turnover but not in collagen fiber content is associated with flow-induced arterial remodeling. J Vasc Res 41 (2004) 546-555
41. Yasmin C., McEniery, Wallace S., et al. loproteinase-9 (MMP-9),MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness [published correction appears in Arterio oscler Thro om mb Vasc Biol. 2005;25:875]. Arterioscler Thromb Vasc Biol 25 (2005) 372
42. Fu J., Lyga A., Shi H., et al. Cloning,expression,purification, and characterization of rat MMP-112. Protein Expr Purif 21 (2001) 268-274